Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

And yes, the ask for the authorized shares to remain whole spells a risk of dilution, one that will likely come to fruition at some point in the future.

That's what I see in the horizons. Not a long term, but short to midterm. Definitely, long before your assumed deadline of 06/2019.
As for the two "bestest" options on the table you mentioned few posts ago, I'd say that neither debt nor a cash influx from the partnership are currently on the table. The fact this management asked for exorbitant number of shares means one things only: that's what they see a path forward. Not even sure if they realize the consequences of doing the R/S and dilution or do they care. The legacy shareholders will be WIPED OUT COMPLETELY. But it's the management's least worries now.